Drugs that have been removed are annotated with the symbol “@” next to the name in the Orange Book. A discontinued drug may be remarketed, for example, when ownership of the New Drug Application (NDA) or Annotated NDA has been purchased by another company that is interested in reintroducing the drug.
Approved drug products are removed from the Orange Book when, for example, an approval is withdrawn under section 505(e)(1) through (5) or 505(j)(6) of the FD&C Act,13 when FDA has determined that the drug product was withdrawn from sale for reasons of safety or effectiveness,14 or when the status of an approval is ...
First-Time Generic Drug Approvals 2024 ANDA NumberBrand Name 57 218112 Dexmedetomidine Injection 56 215592 Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection 55 208112 Relistor (Methylnaltrexone Bromide) Injection 54 214897 Gocovri (Amantadine) Extended-Release Capsules54 more rows
Marketing end date is provided by the labeler upon delisting to identify when the product is no longer in commercial distribution. A future marketing end date means the product has been delisted, but the NDC will remain active until that date is reached.
ECommerce agreements disclose the contractual relationship and obligations between a website owner and its commercial users.
How Do I use the Electronic Orange Book to find approved generic drugs? First, if you have the trade name, search the Electronic Orange Book's Rx or OTC section using the Proprietary Name search. This determines the ingredient(s). Then use the Ingredient Search for all approved products that contain the ingredient(s).
The Orange Book is composed of four parts: (1) approved prescription drug products with therapeutic equivalence evaluations; (2) approved over-the-counter (OTC) drug products for those drugs that may not be marketed without NDAs or ANDAs because they are not subject to 505G; (3) drug products with approval under ...